Showing results (61-70 of 110) with videos related to
Sort By:
Pageof 11
Plos One|September 9, 2016
Anti-Drug Antibodies, Drug Levels, Interleukin-6 and Soluble TNF Receptors in Rheumatoid Arthritis Patients during the First 6 Months of Treatment with Adalimumab or Infliximab: A Descriptive Cohort StudyGrith Petersen Eng, Pierre Bouchelouche, Else Marie Bartels, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|June 13, 2006
Persistence of neutralizing antibodies after discontinuation of IFNbeta therapy in patients with relapsing-remitting multiple sclerosisBodil Petersen, Klaus Bendtzen, Nils Koch-Henriksen, et al.Diabetes, Obesity & Metabolism|May 29, 2023
Sulfatide inhibits fibroblast growth, activation and oxidative stress induced by ectopic insulinAllan Roeske-Nielsen, Jan-Eric Månsson, Hasim Tekin, et al.Journal of Crohn'S & Colitis|January 21, 2012
Acute and delayed hypersensitivity reactions to infliximab and adalimumab in a patient with Crohn's diseaseCasper Steenholdt, Morten Svenson, Klaus Bendtzen, et al.Autoimmunity|April 25, 2007
Gene expression profiling in autoimmune diseases: chronic inflammation or disease specific patterns?Lone Frier Bovin, Jørn Brynskov, Laszlo Hegedüs, et al.Journal of Clinical Immunology|April 8, 2006
Self-reactive CD4+ T cells and B cells in the blood in health and autoimmune disease: increased frequency of thyroglobulin-reactive cells in Graves' diseaseClaus H Nielsen, Ane Christine Moeller, Laszlo Hegedüs, et al.Journal of Periodontology|December 5, 2008
Involvement of interleukin-1 genotypes in the association of coronary heart disease with periodontitisKaren Geismar, Christian Enevold, Lars Korsbaek Sørensen, et al.Journal of Clinical Gastroenterology|July 14, 2015
Time Course and Clinical Implications of Development of Antibodies Against Adalimumab in Patients With Inflammatory Bowel DiseaseCasper Steenholdt, Madeline T Frederiksen, Klaus Bendtzen, et al.The Annals of Thoracic Surgery|April 27, 2010
Cell saver for on-pump coronary operations reduces systemic inflammatory markers: a randomized trialSune Damgaard, Claus H Nielsen, Lars W Andersen, et al.Clinical Immunology (Orlando, Fla.)|July 26, 2008
The effect of beta-interferon therapy on myelin basic protein-elicited CD4+ T cell proliferation and cytokine production in multiple sclerosisChris J Hedegaard, Martin Krakauer, Klaus Bendtzen, et al.Pageof 11